Is AgNOR and DNA ploidy analysis useful for evaluating thyroid neoplasms?

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 3, 2005, Pages 157-161

  Camargo, Roberto Souza ^a   Maeda, Marina Yoshie Sakamoto ^b   Loreto, Celso Di ^b   Shirata, Neuza Kasumi ^b   Garcia, Eduardo Anselme ^b   Filho Longatto, Adhemar ^b,c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

^d NONE   (Brazil)

Author keywords

DNA; Nucleolus organizer region; Ploidies; Thyroid cancer; Thyroid neoplasms

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CHROMOSOME NOR; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DNA CONTENT; DNA DETERMINATION; HISTOGRAM; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSCOPE; ONCOCYTOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SILVER STAINING; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR CLASSIFICATION; UNDIFFERENTIATED CARCINOMA;

EID: 22144471230     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Casella C, Fusco M: Thyroid cancer. Epidemiol Prev 2004;28: 88-91
2. Cuccuru G, Lanzi C, Cassinelli G, Pratesi G, Tortoreto M, Petrangolini G, Seregni E, Martinetti A, Laccabue D, Zanchi C, Zunino F: Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma. J Natl Cancer Inst 2004;96:1006-1014
3. Lee S, Hong SW, Shin SJ, Kim YM, Rhee Y, Jeon BI, Moon WC, Oh MR, Lim SK: Papillary thyroid carcinoma associated with familial adenomatous polyposis: Molecular analysis of pathogenesis in a family and review of the literature. Endocrinol J 2004;51:317-323
4. Tisell LE, Oden A, Muth A, Altiparmak G, Molne J, Ahlman H, Nilsson O: The Ki67 index: A prognostic marker in medullary thyroid carcinoma. Br J Cancer 2003;89:2093-2097
5. Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G: Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas. Endocrinol Pathol 2001;12:275-279
6. Camargo RS, Longatto Filho A, Loreto C, Kanamura CT, Garcia EA: Clinicopathologic evaluation of thyroid through p53 protein accumulation and proliferative activity measured using Ki-67 and PCNA monoclonal antibodies. Folha Med 2002;121:221-225
7. Camargo RS, Scafuri AG, de Tolosa EM, Ferreira EA: DNA image cytometric analysis of differentiated thyroid adenocarcinoma specimens. Am J Surg 1992;164:640-645
8. Nadjari B, Motherby H, Pooschke T, Pooschke S, Gabbert HE, Simon D, Roher HD, Feldkamp J, Tharandt L, Böcking A: DNA aneuploidy as a specific marker of neoplastic cells in FNAB of the thyroid. Analyt Quant Cytol Histol 1999;21: 481-488
9. Onaran Y, Tezelman S, Gurel N, Terzioglu T, Oguz H, Tanakol R, Kapran Y: The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region. Acta Chir Belg 1999;99:30-35
10. Konarska L, Skierski J, Ellert A, Steinbrich J, Wozniak A, Kalczak M: Comparative studies of nuclear DNA content in benign and malignant thyroid lesions. Acta Biochim Pol 2001;48:783-793
11. Stern Y, Segal K, Medalia O, Feinmesser R: DNA ploidy in papillary carcinoma of the thyroid gland in children and adolescents. Int J Pediatr Otorhinolaryngol 1998;46:67-70
12. Castro P, Sansonetty F, Soares P, Dias A, Sobrinho-Simoes M: Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern. Virchows Arch 2001;438:336-342
13. Augustynowicz A, Dzieciol J, Dadan J, Puchalski Z, Sulkowski S: Proliferative activity of the thyroid oxyphilic tumor cells estimated by means of quantitative analysis of silver stained nucleolar organizer regions (AgNORs). Folia Histochem Cytobiol (suppl 2) 2001;39:203-204
14. Pich A, Chiusa L, Margaria E: Prognostic relevance of AgNOR in tumor pathology. Micron 2000;31:133-141
15. Trerè D: AgNOR staining and quantification. Micron 2000; 31:127-131
16. Derenzini M: The AgNORs. Micron 2000;31:117-120
17. Mehrotra A, Goel MM, Singh K: Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions. Analyt Quant Cytol Histol 2002;24:205-211
18. Kawasaki F, Onoda N, Ishikawa T, Ogawa Y, Ikeda K, Sugano S, Kato Y, Chung KH: Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in differentiated thyroid carcinoma as an indicator for disease recurrence. Oncol Rep 2000;7:853-857
19. Hedinger C, Williams ED, Sobin LH: Histological typing of thyroid tumours. In International Histological Classification of Tumours. Second edition. Berlin, Springer-Verlag, 1988
20. Greene FL, Sobin L: The TNM System: Our language for cancer care. J Surg Oncol 2002;80:119-120
21. Böcking A, Adler CP, Xommon HH, Hilgarth M, Granzen B, Auffermann W: Algorithm for DNA-cytophotometric diagnosis and grading of malignancy. Analyt Quant Cytol Histol 1984;6:1-8
22. Campos-Filho N, Franco ELF: Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Comput Methods Progr Biomed 1988;27:223-228
23. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
24. Cox DR: Regression models and life tables. J R Stat Soc 1972; 34:187-220
25. Wu HS, Young MT, Ituarte PH, D'Avanzo A, Duh QY, Greenspan FS, Loh KC, Clark OH: Death from thyroid cancer of follicular cell origin. J Am Coll Surg 2000;191:600-606
26. D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE, Clark OH: Prognostic scoring systems in patients with follicular thyroid cancer: A comparison of different staging systems in predicting the patient outcome. Thyroid 2004;14:453-458
27. Camargo RS, Tolosa EMC, Garcia ME, et al: DNA evaluation by cytophotometry in papillary tumors of the thyroid. Rev Col Bras Cirur 1990;17:90-93
28. Joensuu H, Klemi PJ: Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Am J Clin Pathol 1988;89:35-40
29. Slowinska-Klencka D, Klencki M, Popowicz B, Sporny S, Lewinski A: Multiparameter analysis of AgNOR in thyroid lesions: Comparison with PCNA expression. Histol Histopathol 2004;19:785-792